Leveraging human evolutionary history to improve our understanding of complex disease architecture

利用人类进化史来提高我们对复杂疾病结构的理解

基本信息

  • 批准号:
    10752744
  • 负责人:
  • 金额:
    $ 24.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Title: Leveraging human evolutionary history to improve our fundamental understanding of complex disease architecture Abstract: The overarching goal of this research is to improve the applicability of genetic risk predictions within and across human populations by leveraging recent advances in our understanding of human evolutionary history. In Aim 1, I will carry out empirically-guided simulations to investigate how fine-scale substructure in large genome-wide association studies (GWAS; e.g. UK Biobank) biases our inference of complex trait architecture and polygenic risk score prediction. I will leverage these findings to develop statistical and computational tools to correct for such biases. In Aim 2, I will investigate whether recent admixture in humans generates incompatibilities between mitochondrial and nuclear DNA in African Americans. To test this, I will analyze genetic and electronic health record data from the ethnically diverse Penn Medicine Biobank to test whether mito-nuclear discordance—degree of ancestry divergence between mitochondrial and nuclear genomes—is associated with the risk of diseases common among African Americans. Additionally, I will test for selection against mito-nuclear incompatibilities in recently admixed populations. In Aim 3, I will investigate how the practice of endogamy and consanguinity among Pakistanis shapes their disease risk architecture. I will further evaluate the ability and limitations of currently used GWAS methods, which are typically modeled after outbred populations, to infer disease architecture given the complex population structure in Pakistanis. I will improve upon these methods, thereby making GWAS more widely applicable to a diverse set of people. Each of my three aims is independent, yet together they will lead to improvements in diagnosis, treatment, and prevention of human diseases—the overarching mission of the NIGMS. I will learn the skills needed to accomplish these aims with the help of my advisory committee, comprising of Drs. Iain Mathieson, Sarah Tishkoff, Doug Wallace, and Marilyn Ritchie, who are world-class leaders in genetics research. With the training plan that I have outlined and the resources at the University of Pennsylvania, I am confident that the K99 award will help me achieve my goal of becoming an independent scientist in the field of statistical genetics.
题目:利用人类进化史来提高我们的基本认识

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Syed Arslan Abbas Zaidi其他文献

Syed Arslan Abbas Zaidi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Syed Arslan Abbas Zaidi', 18)}}的其他基金

Leveraging human evolutionary history to improve our understanding of complex disease architecture
利用人类进化史来提高我们对复杂疾病结构的理解
  • 批准号:
    10456685
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10818088
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans
非裔美国人冠心病和相关代谢组标记物的混合图谱
  • 批准号:
    10571022
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
  • 批准号:
    10590405
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
NSF Postdoctoral Fellowship in Biology: Coalescent Modeling of Sex Chromosome Evolution with Gene Flow and Analysis of Sexed-versus-Gendered Effects in Human Admixture
NSF 生物学博士后奖学金:性染色体进化与基因流的合并模型以及人类混合中性别与性别效应的分析
  • 批准号:
    2305910
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Fellowship Award
Admixture mapping of mosaic copy number alterations for identification of cancer drivers
用于识别癌症驱动因素的马赛克拷贝数改变的混合图谱
  • 批准号:
    10608931
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients
利用微生物组、局部混合物和机器学习来优化医疗服务不足的患者的抗凝药物基因组学
  • 批准号:
    10656719
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
The role of admixture in human evolution
混合物在人类进化中的作用
  • 批准号:
    10683318
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
Genealogical ancestors, admixture, and population history
家谱祖先、混合和人口历史
  • 批准号:
    2116322
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Standard Grant
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10307040
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
  • 批准号:
    10307680
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了